Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_283
Snippet: Tylosin had a profound effect on the fecal microbiota, which in some dogs persisted for at least 2 months. Further studies are warranted to determine if dysbiosis secondary to antimicrobial administration increases patient risk of developing disease, intestinal or otherwise, in the future. Pancreatitis may cause extrahepatic bile duct obstruction secondary to local inflammation in the vicinity of the common bile duct. To date, there has been limi.....
Document: Tylosin had a profound effect on the fecal microbiota, which in some dogs persisted for at least 2 months. Further studies are warranted to determine if dysbiosis secondary to antimicrobial administration increases patient risk of developing disease, intestinal or otherwise, in the future. Pancreatitis may cause extrahepatic bile duct obstruction secondary to local inflammation in the vicinity of the common bile duct. To date, there has been limited evidence to support the optimal treatment for this condition. The purpose of this study was to describe the clinical presentation and outcome of dogs that develop extrahepatic bile duct obstruction secondary to pancreatitis, and assess factors associated with survival.
Search related documents:
Co phrase search for related documents- antimicrobial administration and patient risk: 1, 2
- antimicrobial administration and study purpose: 1
- bile duct and clinical presentation: 1
- bile duct and common bile duct: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- bile duct and duct obstruction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- bile duct and extrahepatic bile: 1, 2, 3, 4, 5, 6, 7, 8, 9
- bile duct and extrahepatic bile duct: 1, 2, 3, 4, 5, 6, 7, 8
- bile duct and extrahepatic bile duct obstruction: 1, 2, 3
- bile duct and extrahepatic bile pancreatitis secondary duct obstruction: 1
- bile duct and pancreatitis secondary duct obstruction: 1
- bile duct and patient risk: 1
- bile duct and study purpose: 1, 2, 3, 4, 5, 6
- clinical presentation and common bile duct: 1
- clinical presentation and develop disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- clinical presentation and fecal microbiota: 1
- clinical presentation and local inflammation: 1, 2
- clinical presentation and optimal treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- clinical presentation and patient risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- clinical presentation and study purpose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
Co phrase search for related documents, hyperlinks ordered by date